Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
2 "Quality of care"
Filter
Filter
Article category
Keywords
Publication year
Authors
Review
IBD
Improving the quality of care for inflammatory bowel disease
Byong Duk Ye, Simon Travis
Intest Res 2019;17(1):45-53.   Published online November 20, 2018
DOI: https://doi.org/10.5217/ir.2018.00113
AbstractAbstract PDFPubReaderePub
Great strides have been achieved in the development of quality-of-care measures and standards for inflammatory bowel disease (IBD) over the last decade. The central structural component of care in IBD revolves around the multidisciplinary team, which should be equipped with the necessary resources to operate and implement decisions. Process measures have been defined by interest groups and can be adapted into process tools for the delivery of care for various patient subgroups and clinical scenarios. The emerging treat-to-target approach to IBD management may be used to achieve optimal long-term and holistic patient-centred outcomes, such as survival, control of inflammation and disease progression, symptomatic remission, quality of life and complications. Other important quality-of-care outcome measures for IBD include disutility of care, healthcare utilization and other patient-reported outcomes such as nutritional status and impact of fistulae. The current challenge for healthcare providers and health systems is the integration of quality-of-care structures and processes into clinical practice, and the consistent delivery of updated evidence-based quality IBD care to various patient populations by individual health care providers. Finally, the awareness and appreciation for quality of care in IBD is increasing in Asia, and Asian healthcare institutions should be encouraged to take the lead in improving the quality of care in IBD.

Citations

Citations to this article as recorded by  
  • Improving access to inflammatory bowel disease care in Canada: The patient experience
    Shehzeen Lalani, Holly Mathias, Courtney Heisler, Noelle Rohatinsky, Raza M Mirza, Olga Kits, Sandra Zelinsky, Geoffrey Nguyen, Peter L Lakatos, Sharyle Fowler, Kevin Rioux, Jennifer L Jones
    Journal of Health Services Research & Policy.2025; 30(1): 12.     CrossRef
  • Identification and prioritization of patient-centred strategies to enhance IBD-related care for older adults: a modified Delphi approach
    Noelle Rohatinsky, Natasha Tooke, Sharyle Fowler, Christian Rueda-Clausen, Dirk Morrison, Judith Winchester, Juan-Nicolás Peña-Sánchez
    Journal of the Canadian Association of Gastroenterology.2024; 7(5): 384.     CrossRef
  • Person-Centered Coordinated Care Experience of People With Long-Term Conditions in the Balearic Islands Measured by the P3CEQ
    Gabriel Mercadal-Orfila, Salvador Herrera-Pérez, Núria Piqué, Francesc Mateu-Amengual, Pedro Ventayol-Bosch, Maria Antonia Maestre-Fullana, Joaquin Ignacio Serrano-López de las Hazas, Francisco Fernández-Cortés, Francesc Barceló- Sansó, Santiago Rios
    Health Services Insights.2024;[Epub]     CrossRef
  • Empowering inflammatory bowel disease patients with at-home remote disease and therapeutic drug monitoring
    Graham Johnson
    Gastrointestinal Nursing.2024; 22(7): 337.     CrossRef
  • Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?
    Padhmanand Sudhakar, Judith Wellens, Bram Verstockt, Marc Ferrante, João Sabino, Séverine Vermeire
    Gut.2023; 72(1): 192.     CrossRef
  • The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
    Johan Burisch, Mirabella Zhao, Selwyn Odes, Peter De Cruz, Severine Vermeire, Charles N Bernstein, Gilaad G Kaplan, Dana Duricova, Dan Greenberg, Hans O Melberg, Mamoru Watanabe, Hyeong Sik Ahn, Laura Targownik, Valérie E H Pittet, Vito Annese, KT Park, K
    The Lancet Gastroenterology & Hepatology.2023; 8(5): 458.     CrossRef
  • The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care
    Holly Mathias, Noelle Rohatinsky, Sanjay K Murthy, Kerri Novak, M Ellen Kuenzig, Geoffrey C Nguyen, Sharyle Fowler, Eric I Benchimol, Stephanie Coward, Gilaad G Kaplan, Joseph W Windsor, Charles N Bernstein, Laura E Targownik, Juan-Nicolás Peña-Sánchez, K
    Journal of the Canadian Association of Gastroenterology.2023; 6(Supplement): S111.     CrossRef
  • Der IBD-Control-Fragebogen: Deutsche Übertragung und Validierung des standardisierten Fragebogens zur Messung des Outcomes aus Patientensicht bei chronisch entzündlichen Darmerkrankungen
    Annabell Müller, Selina Simone Bilger, Andreas Göldi, Gunther Meinlschmidt, Florian Rueter, Alexander Kappes, Petr Hruz, Christoph Andreas Meier, Jan Hendrik Niess
    Zeitschrift für Gastroenterologie.2022; 60(06): 911.     CrossRef
  • High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases
    Hyung Jin Ahn, Ye-Jee Kim, Ho-Su Lee, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Beom-Jun Kim, Sang Hyoung Park
    Clinical Gastroenterology and Hepatology.2022; 20(5): e1022.     CrossRef
  • Appendiceal Orifice Inflammation Is Associated with Lower Rate of Complete Endoscopic Remission in Patients with Ulcerative Colitis
    Chang Kyo Oh, Han Hee Lee, Jin Su Kim, Bo-In Lee, Young-Seok Cho
    Journal of Personalized Medicine.2022; 12(5): 748.     CrossRef
  • Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment
    Soo Min Ahn, Jonggi Choi, Byong Duk Ye, Suk-Kyun Yang, Ji Seon Oh, Yong‑Gil Kim, Chang-Keun Lee, Bin Yoo, Sang Hyoung Park, Seokchan Hong
    Gut and Liver.2022; 16(4): 567.     CrossRef
  • Clinical Remission and Psychological Management are Major Issues for the Quality of Life in Pediatric Crohn Disease
    Anne Gourdonneau, Léa Bruneau, Frank M. Ruemmele, Lorenzo Norsa, Armelle Takeda, Catherine Le Gall, Haude Clouzeau, Laurent Rebouissoux, Alain Dabadie, Laure Bridoux‐Henno, Julie Rebeuh, Nadège Thomassin, Jérôme Viala, Stéphanie Willot, Anne Breton, Stéph
    Journal of Pediatric Gastroenterology and Nutrition.2021; 72(1): 74.     CrossRef
  • Trends in hospitalizations and mortality for inflammatory bowel disease from a nationwide database study between 2008 and 2018
    Asim Kichloo, Zain El-amir, Dushyant Singh Dahiya, Farah Wani, Hafeez Shaka
    Baylor University Medical Center Proceedings.2021; 34(5): 550.     CrossRef
  • Classification According to Subjectivity of Inflammatory Bowel Disease Patients Using Q Methodology
    Jun Lee
    The Korean Journal of Gastroenterology.2021; 78(1): 1.     CrossRef
  • Subjective Needs and Thoughts for the Treatment of Patients with Inflammatory Bowel Disease: Applying Q Methodology
    Yong Eun Park, Jin Lee, Jongha Park, Joon Hyuk Choi, Nae Yun Heo, Seung Ha Park, Yoon Kyoung Lee, Tae Oh Kim
    The Korean Journal of Gastroenterology.2021; 78(1): 37.     CrossRef
  • Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
    Jihye Park, Sinyoung Park, Shin Ae Lee, Soo Jung Park, Jae Hee Cheon
    The Korean Journal of Internal Medicine.2021; 36(5): 1040.     CrossRef
  • Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea
    Jae Yong Lee, Kyunghwan Oh, Hee Seung Hong, Kyuwon Kim, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Ho-Su Lee, Kyung-Wook Jo, Sang Hyoung Park
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
    Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen
    Intestinal Research.2020; 18(1): 18.     CrossRef
  • Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005‐2013
    Mustafa Shawihdi, Susanna Dodd, Constantinos Kallis, Pete Dixon, Ruth Grainger, Stuart Bloom, Fraser Cummings, Mike Pearson, Keith Bodger
    Alimentary Pharmacology & Therapeutics.2019; 50(2): 176.     CrossRef
  • 8,028 View
  • 257 Download
  • 20 Web of Science
  • 19 Crossref
Close layer
Original Article
Quality of care in inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul
Hye Kyung Song, Kang-Moon Lee, Sung-Ae Jung, Sung Noh Hong, Dong Soo Han, Suk-Kyun Yang
Intest Res 2016;14(3):240-247.   Published online June 27, 2016
DOI: https://doi.org/10.5217/ir.2016.14.3.240
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

The quality of care in inflammatory bowel disease (IBD) has not been systematically estimated. The aim of this study was to investigate the current status of quality of IBD care in Asian countries.

Methods

A questionnaire-based survey was conducted between March 2014 and May 2014. The questionnaire was adopted from "An adult inflammatory bowel disease physician performance measure set" developed by the American Gastroenterological Association. If the respondent executed the performance measure in more than 70% of patients, the measure was regarded as well performed.

Results

A total of 353 medical doctors from Asia completed the survey (116 from Korea, 114 from China, 88 from Japan, 17 from Taiwan, 8 from Hong-Kong, 4 from India, 3 from Singapore, and 1 each from the Philippines, Malaysia and Indonesia). The delivery of performance measures, however, varied among countries. The documentation of IBD and tuberculosis screening before anti-tumor necrosis factor therapy were consistently performed well, while pneumococcal immunization and prophylaxis of venous thromboembolisms in hospitalized patients were performed less frequently in all countries. Physician awareness was positively associated with the delivery of performance measures. Variations were also noted in reasons for non-performance or low performance of quality measures, and the two primary reasons cited were consideration of the measure to be unimportant and lack of time.

Conclusions

The delivery of performance measures varies among physicians in Asian countries, and reflects variations in the quality of care among the countries. This variation should be recognized to improve the quality of care in Asian countries.

Citations

Citations to this article as recorded by  
  • The Incidence and Predictive Factors of Thromboembolism During Hospitalizations for Inflammatory Bowel Disease Flare‐Ups: A Retrospective Cohort Study in Taiwan
    Ming‐Jung Meng, Chen‐Shuan Chung, Chen‐Wang Chang, Yu‐Bin Pan, Chia‐Jung Kuo, Cheng‐Tang Chiu, Puo‐Hsien Le
    Journal of Evaluation in Clinical Practice.2024;[Epub]     CrossRef
  • Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
    Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, Sang Hyoung Park, Choon Jin Ooi, Ajit Sood, Jong Pil Im
    Intestinal Research.2023; 21(3): 353.     CrossRef
  • Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
    Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
    Intestinal Research.2023; 21(3): 339.     CrossRef
  • IBD barriers across the continents – East Asia
    Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
    Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
  • Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study
    Su Young Kim, Yeon Seo Cho, Hyun-Soo Kim, Jung Kuk Lee, Hee Man Kim, Hong Jun Park, Hyunil Kim, Jihoon Kim, Dae Ryong Kang
    Gut and Liver.2022; 16(4): 555.     CrossRef
  • Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study
    Chan Mi Heo, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Mi Yang, Seonwoo Kim, Young-Ho Kim
    Scientific Reports.2021;[Epub]     CrossRef
  • Incidence and risk factors for venous thrombosis among patients with inflammatory bowel disease in China: a multicenter retrospective study
    Jing Liu, Xiang Gao, Ye Chen, Qiao Mei, Liangru Zhu, Jiaming Qian, Pinjin Hu, Qian Cao
    Intestinal Research.2021; 19(3): 313.     CrossRef
  • Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
    Yunho Jung
    The Korean Journal of Gastroenterology.2020; 75(1): 1.     CrossRef
  • Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia
    Rupa Banerjee, Partha Pal, Joyce Wing Yan Mak, Siew C Ng
    The Lancet Gastroenterology & Hepatology.2020; 5(12): 1076.     CrossRef
  • Quality of care in inflammatory bowel disease: actual health service experiences fall short of the standards
    Antonina Mikocka‐Walus, Wayne Massuger, Simon R. Knowles, Gregory T. Moore, Stephanie Buckton, William Connell, Paul Pavli, Leanne Raven, Jane M. Andrews
    Internal Medicine Journal.2020; 50(10): 1216.     CrossRef
  • Improving the quality of care for inflammatory bowel disease
    Byong Duk Ye, Simon Travis
    Intestinal Research.2019; 17(1): 45.     CrossRef
  • Should Asian inflammatory bowel disease patients need routine thromboprophylaxis?
    Meng-Tzu Weng, Chien-Chih Tung, Jau-Min Wong, Shu-Chen Wei
    Intestinal Research.2018; 16(2): 312.     CrossRef
  • Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies
    Lorant Gonczi, Zsuzsanna Kurti, Petra Anna Golovics, Barbara Dorottya Lovasz, Orsolya Menyhart, Anna Seres, Liza Dalma Sumegi, Alexander Gal, Akos Ilias, Papp Janos, Krisztina Barbara Gecse, Talat Bessisow, Waqqas Afif, Alain Bitton, Zsuzsanna Vegh, Peter
    Digestive and Liver Disease.2018; 50(1): 37.     CrossRef
  • Quality indicators in inflammatory bowel disease
    Sameer K. Berry, Gil Y. Melmed
    Intestinal Research.2018; 16(1): 43.     CrossRef
  • Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 1: Risk assessment
    Dong II Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin‐Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
    Journal of Gastroenterology and Hepatology.2018; 33(1): 20.     CrossRef
  • Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
    Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
    Intestinal Research.2018; 16(1): 4.     CrossRef
  • Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study
    Meng-Tzu Weng, Sang Hyoung Park, Katsuyoshi Matsuoka, Chien-Chih Tung, Jae Yong Lee, Chin-Hao Chang, Suk-Kyun Yang, Mamoru Watanabe, Jau-Min Wong, Shu-Chen Wei
    Inflammatory Bowel Diseases.2018; 24(8): 1791.     CrossRef
  • Assessment of factors associated with smoking cessation at diagnosis or during follow‐up of Crohn's disease
    Eun Mi Song, Gwang‐Un Kim, Myeongsook Seo, Sung Wook Hwang, Sang Hyoung Park, Eunja Kwon, Ho‐Su Lee, Dong‐Hoon Yang, Kyung‐Jo Kim, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang
    Journal of Gastroenterology and Hepatology.2018; 33(1): 180.     CrossRef
  • Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?
    Matthew Strohl, Lorant Gonczi, Zsuzsanna Kurt, Talat Bessissow, Peter L Lakatos
    World Journal of Gastroenterology.2018; 24(22): 2363.     CrossRef
  • Changing treatment paradigms for the management of inflammatory bowel disease
    Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
    The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
  • IBD2020 global forum: results of an international patient survey on quality of care
    Peter Irving, Johan Burisch, Richard Driscoll, Mats Olsson, John R Fullarton, Barry S Rodgers-Gray, Simon PL Travis
    Intestinal Research.2018; 16(4): 537.     CrossRef
  • 6,363 View
  • 77 Download
  • 21 Web of Science
  • 21 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP